TY - JOUR
T1 - Group 5 metabotropic glutamate receptors
T2 - Role in modulating cortical activity and relevance to cognition
AU - Homayoun, Houman
AU - Moghaddam, Bita
N1 - Funding Information:
This work has been supported by NIMH.
PY - 2010/8
Y1 - 2010/8
N2 - Group 5 metabotropic glutamate (mGlu5) receptors are abundant in forebrain and limbic regions and provide a novel pharmacological target for modulation of cognition. Here, we review recent advances in understanding the electrophysiology of these receptors which reveal a role for mGlu5 receptors in the regulation of tonic and bursting modes of neuronal firing, maintenance of distinct forms of synaptic plasticity, and reversal of detrimental effects of NMDA receptor antagonism on cortical neuronal activity. Furthermore, recordings using recently developed positive allosteric modulators of the mGlu5 receptor suggest that these agents have an electrophysiological profile comparable to the antipsychotic agent clozapine. These findings, in conjunction with behavioral evidence from preclinical studies of cognition, suggest a potential precognitive profile for the mGlu5 receptor potentiators.
AB - Group 5 metabotropic glutamate (mGlu5) receptors are abundant in forebrain and limbic regions and provide a novel pharmacological target for modulation of cognition. Here, we review recent advances in understanding the electrophysiology of these receptors which reveal a role for mGlu5 receptors in the regulation of tonic and bursting modes of neuronal firing, maintenance of distinct forms of synaptic plasticity, and reversal of detrimental effects of NMDA receptor antagonism on cortical neuronal activity. Furthermore, recordings using recently developed positive allosteric modulators of the mGlu5 receptor suggest that these agents have an electrophysiological profile comparable to the antipsychotic agent clozapine. These findings, in conjunction with behavioral evidence from preclinical studies of cognition, suggest a potential precognitive profile for the mGlu5 receptor potentiators.
KW - Cognitive enhancer
KW - Metabotropic glutamate receptor 5
KW - NMDA glutamate receptor
KW - Prefrontal cortex
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=77953615107&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953615107&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2009.12.042
DO - 10.1016/j.ejphar.2009.12.042
M3 - Review article
C2 - 20371231
AN - SCOPUS:77953615107
SN - 0014-2999
VL - 639
SP - 33
EP - 39
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-3
ER -